All AbMole products are for research use only, cannot be used for human consumption.
Siramesine(Lu 28-179) is a selective sigma-2 receptor agonist, which has been shown to trigger cell death of cancer cells and to exhibit a potent anticancer activity in vivo. Siramesine can induce cell death in transformed cells through a mechanism including lysosomal destabilization.
In vivo, siramesine treatment of mice caused a depletion of the MC populations of the peritoneum and skin.
Molecular Weight | 454.58 |
Formula | C30H31FN2O |
CAS Number | 147817-50-3 |
Solubility (25°C) | DMSO |
Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
Related Sigma Receptor Products |
---|
ANAVEX 3-71
ANAVEX 3-71 is an orally active SIGMAR1 receptor agonist and M1-positive variant modulator for studies related to schizophrenia. |
Blarcamesine
Blarcamesine is a Sigma-1 receptor agonist and muscarinic receptor modulator with neuroprotective and antidepressant activity. In addition, Blarcamesine ameliorates neurological impairment in a mouse model of Rett syndrome. |
AB10
AB10 is a selective S1R antagonist. |
WLB-89462
WLB-89462 is a selective σ2 receptor ligand (Ki: 13 nM). |
Siramesine fumarate
Siramesine (Lu 28-179) fumarate is a potent sigma-2 receptor agonist. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.